Prudential PLC Boosts Position in Humana Inc. (NYSE:HUM)

Prudential PLC lifted its holdings in Humana Inc. (NYSE:HUM - Free Report) by 161.5% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 9,332 shares of the insurance provider's stock after purchasing an additional 5,764 shares during the period. Prudential PLC's holdings in Humana were worth $2,368,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Nicolet Advisory Services LLC increased its position in shares of Humana by 42.8% during the fourth quarter. Nicolet Advisory Services LLC now owns 1,624 shares of the insurance provider's stock worth $437,000 after acquiring an additional 487 shares during the period. Cinctive Capital Management LP purchased a new stake in Humana during the 4th quarter worth about $2,706,000. Massachusetts Financial Services Co. MA raised its position in Humana by 59.5% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 624,756 shares of the insurance provider's stock valued at $158,507,000 after purchasing an additional 233,099 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Humana by 2.3% in the 4th quarter. Geode Capital Management LLC now owns 2,883,614 shares of the insurance provider's stock valued at $729,658,000 after buying an additional 63,562 shares during the period. Finally, HighPoint Advisor Group LLC grew its position in shares of Humana by 6.1% during the fourth quarter. HighPoint Advisor Group LLC now owns 1,509 shares of the insurance provider's stock worth $388,000 after buying an additional 87 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Humana Stock Performance

Humana stock traded up $1.15 during mid-day trading on Friday, reaching $291.40. 515,615 shares of the company were exchanged, compared to its average volume of 1,743,697. The firm has a market cap of $35.17 billion, a PE ratio of 29.27, a price-to-earnings-growth ratio of 2.05 and a beta of 0.62. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The firm's 50-day simple moving average is $265.56 and its two-hundred day simple moving average is $270.77. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $406.46.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Equities analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a yield of 1.21%. Humana's payout ratio is currently 35.58%.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. StockNews.com upgraded shares of Humana from a "hold" rating to a "buy" rating in a research note on Monday. JPMorgan Chase & Co. decreased their price objective on shares of Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a research report on Tuesday, February 18th. Morgan Stanley dropped their target price on Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a report on Wednesday, February 12th. Royal Bank of Canada restated an "outperform" rating and issued a $283.00 price target on shares of Humana in a research note on Wednesday, February 12th. Finally, Piper Sandler increased their price objective on Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a report on Wednesday, January 15th. Seventeen analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $286.00.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.